Login Register Cart 0
Generic placeholder image

Recent Patents on Anti-Cancer Drug Discovery

Editor-in-Chief

ISSN (Print): 1574-8928
ISSN (Online): 2212-3970

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Targeting Ferroptosis as a New Approach for Radiation Protection and Mitigation

Author(s): Zahra Shaghaghi, Arsalan Salari, Fatemeh Jalali, Maryam Alvandi, Soghra Farzipour* and Nasim Zarei Polgardani

Volume 19, Issue 1, 2024

Published on: 08 February, 2023

Page: [57 - 71] Pages: 15

DOI: 10.2174/1574892818666230119153247

Price: $65

Abstract

Radiation-induced normal cell toxicity (RINCT) is a major factor to consider while treating any ailment with radiotherapy. Clinical irradiation of tumors necessitates an understanding of the potential efficacy of radiation protective agents in reducing radiation damage to healthy tissues and their effects on tumor tissue radiosensitivity. Ferroptosis is a relatively new form of iron-dependent cell death that has been linked to a variety of disease pathologies. The key mediators of ferroptosis have been identified as lipid peroxidation and iron metabolism. Lipid peroxidation is the result of a reaction between reactive oxygen (ROS) and reactive nitrogen species (RNS) with phosphatidylethanolamine-containing polyunsaturated fatty acids (PUFAs). Ferroptosis inhibitors have been demonstrated to have anti-inflammatory effects in animal models of disease. It was recently shown that ionizing radiation (IR) generates severe ferroptosis, a critical component of RT-mediated normal cell toxicity. These findings support the use of ferroptosis inhibitor treatments for the treatment of radiation normal cell toxicity. Targeting lipid metabolic substrates and controlling ferroptosis by radiation could reduce toxicity and improve clinical outcomes. In this study, we address the relationships between radiotherapy and various types of radiation-induced cell death, and we discuss the interactions between ferroptosis and other kinds of controlled cell death generated by radiotherapy, and we investigate combination treatment options targeting ferroptosis in radiotherapy. This review will be a foundation for future research on ferroptosis in radiotherapy. Additionally, the relevant patents on ferroptosis inhibitors with various therapeutic potentials have been discussed.

« Previous Next »
[1]
Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther 2020; 5(1): 60.
[http://dx.doi.org/10.1038/s41392-020-0150-x] [PMID: 32355263]
[2]
Yu T, Zhang Q, Zheng T, et al. The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: A meta-analysis of the literatures: A meta-analysis of the literatures. PLoS One 2016; 11(5): e0154499.
[http://dx.doi.org/10.1371/journal.pone.0154499] [PMID: 27171271]
[3]
Asghari M, Shaghaghi Z, Farzipour S, Ghasemi A, Hosseinimehr SJ. Radioprotective effect of olanzapine as an anti-psychotic drug against genotoxicity and apoptosis induced by ionizing radiation on human lymphocytes. Mol Biol Rep 2019; 46(6): 5909-17.
[http://dx.doi.org/10.1007/s11033-019-05024-x] [PMID: 31407246]
[4]
Yahyapour R, Motevaseli E, Rezaeyan A, et al. Reduction-oxidation (redox) system in radiation-induced normal tissue injury: Molecular mechanisms and implications in radiation therapeutics. Clin Transl Oncol 2018; 20(8): 975-88.
[http://dx.doi.org/10.1007/s12094-017-1828-6] [PMID: 29318449]
[5]
Imai H, Matsuoka M, Kumagai T, Sakamoto T, Koumura T. Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr Top Microbiol Immunol 2016; 403: 143-70.
[http://dx.doi.org/10.1007/82_2016_508] [PMID: 28204974]
[6]
Hervouet E, Cheray M, Vallette F, Cartron PF. DNA methylation and apoptosis resistance in cancer cells. Cells 2013; 2(3): 545-73.
[http://dx.doi.org/10.3390/cells2030545] [PMID: 24709797]
[7]
Citrin DE, Mitchell JB. Mechanisms of normal tissue injury from irradiation. Semin Radiat Oncol 2017; 27(4): 316-24.
[http://dx.doi.org/10.1016/j.semradonc.2017.04.001] [PMID: 28865514]
[8]
Sia J, Szmyd R, Hau E, Gee HE. Molecular mechanisms of radiation-induced cancer cell death: A Primer. Front Cell Dev Biol 2020; 8: 41.
[http://dx.doi.org/10.3389/fcell.2020.00041] [PMID: 32117972]
[9]
Akleyev AV. Normal tissue reactions to chronic radiation exposure in man. Radiat Prot Dosimetry 2016; 171(1): 107-16.
[http://dx.doi.org/10.1093/rpd/ncw207] [PMID: 27473696]
[10]
Szejk M. Kołodziejczyk-Czepas J, Żbikowska HM. Radioprotectors in radiotherapy - advances in the potential application of phytochemicals. Postepy Hig Med Dosw 2016; 70(0): 722-34.
[http://dx.doi.org/10.5604/17322693.1208039] [PMID: 27356603]
[11]
Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15(4): 360-71.
[http://dx.doi.org/10.1634/theoncologist.2009-S104] [PMID: 20413641]
[12]
Nicolatou-Galitis O, Sarri T, Bowen J, et al. Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 2013; 21(1): 357-64.
[http://dx.doi.org/10.1007/s00520-012-1613-6] [PMID: 23052919]
[13]
Pan J, He H, Su Y, et al. GST-TAT-SOD: Cell permeable bifunctional antioxidant enzyme - a potential selective radioprotector. Oxid Med Cell Longev 2016; 2016: 1-13.
[http://dx.doi.org/10.1155/2016/5935080] [PMID: 27313832]
[14]
Terasaki Y, Ohsawa I, Terasaki M, et al. Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress. Am J Physiol Lung Cell Mol Physiol 2011; 301(4): L415-26.
[http://dx.doi.org/10.1152/ajplung.00008.2011] [PMID: 21764987]
[15]
Lei G, Zhang Y, Koppula P, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res 2020; 30(2): 146-62.
[http://dx.doi.org/10.1038/s41422-019-0263-3] [PMID: 31949285]
[16]
Zhang XL, Xing RG, Chen L, Liu CR, Miao ZG. PI3K/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition. Mol Med Rep 2016; 14(6): 5699-706.
[http://dx.doi.org/10.3892/mmr.2016.5960] [PMID: 27878273]
[17]
Bao W, Liu X, Lv Y, et al. Nanolongan with multiple on-demand conversions for ferroptosis-apoptosis combined anticancer therapy. ACS Nano 2019; 13(1): 260-73.
[http://dx.doi.org/10.1021/acsnano.8b05602] [PMID: 30616348]
[18]
Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol 2020; 30(6): 478-90.
[http://dx.doi.org/10.1016/j.tcb.2020.02.009] [PMID: 32413317]
[19]
Li J, Cao F, Yin H, et al. Ferroptosis: Past, present and future. Cell Death Dis 2020; 11(2): 88.
[http://dx.doi.org/10.1038/s41419-020-2298-2] [PMID: 32015325]
[20]
Farzipour S, Talebpour Amiri F, Alvandi M, Shaghaghi Z, Yazdi A. Ferroptosis in cardiovascular disease: Basic mechanisms and implications for cardiovascular disease. J Maz Univ Med Sci 2021; 31(200): 199-214.
[21]
Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 2019; 575(7784): 693-8.
[http://dx.doi.org/10.1038/s41586-019-1707-0] [PMID: 31634899]
[22]
Qu M, Zhang H, Chen Z, et al. The role of ferroptosis in acute respiratory distress syndrome. Front Med 2021; 8: 651552.
[http://dx.doi.org/10.3389/fmed.2021.651552] [PMID: 34026785]
[23]
Sun Y, Chen P, Zhai B, et al. The emerging role of ferroptosis in inflammation. Biomed Pharmacother 2020; 127: 110108.
[http://dx.doi.org/10.1016/j.biopha.2020.110108] [PMID: 32234642]
[24]
Kuang F, Liu J, Tang D, Kang R. Oxidative damage and antioxidantdefense in ferroptosis. Front Cell Dev Biol 2020; 8: 586578.
[http://dx.doi.org/10.3389/fcell.2020.586578] [PMID: 33043019]
[25]
Ren JX, Li C, Yan XL, Qu Y, Yang Y, Guo ZN. Crosstalk between oxidative stress and ferroptosis/oxytosis in ischemic stroke: Possible targets and molecular mechanisms. Oxid Med Cell Longev 2021; 2021: 1-13.
[http://dx.doi.org/10.1155/2021/6643382] [PMID: 34055196]
[26]
Weiland A, Wang Y, Wu W, et al. Ferroptosis and its role in diverse brain diseases. Mol Neurobiol 2019; 56(7): 4880-93.
[http://dx.doi.org/10.1007/s12035-018-1403-3] [PMID: 30406908]
[27]
Jiang X, Stockwell BR, Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021; 22(4): 266-82.
[http://dx.doi.org/10.1038/s41580-020-00324-8] [PMID: 33495651]
[28]
Wang Y, Quan F, Cao Q, et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res 2021; 28: 231-43.
[http://dx.doi.org/10.1016/j.jare.2020.07.007] [PMID: 33364059]
[29]
Angeli JPF, Shah R, Pratt DA, Conrad M. Ferroptosis inhibition: Mechanisms and opportunities. Trends Pharmacol Sci 2017; 38(5): 489-98.
[http://dx.doi.org/10.1016/j.tips.2017.02.005] [PMID: 28363764]
[30]
Li C, Dong X, Du W, et al. LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis. Signal Transduct Target Ther 2020; 5(1): 187.
[http://dx.doi.org/10.1038/s41392-020-00297-2] [PMID: 32883948]
[31]
Skouta R, Dixon SJ, Wang J, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 2014; 136(12): 4551-6.
[http://dx.doi.org/10.1021/ja411006a] [PMID: 24592866]
[32]
Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 2014; 16(12): 1180-91.
[http://dx.doi.org/10.1038/ncb3064] [PMID: 25402683]
[33]
Burton GW, Hughes L, Ingold KU. Antioxidant activity of phenols related to vitamin E. Are there chain-breaking antioxidants better than. alpha. tocopherol? J Am Chem Soc 1983; 105(18): 5950-1.
[http://dx.doi.org/10.1021/ja00356a057]
[34]
Lucarini M, Pedulli GF, Cipollone M. Bond dissociation enthalpy of. alpha. tocopherol and other phenolic antioxidants. J Org Chem 1994; 59(17): 5063-70.
[http://dx.doi.org/10.1021/jo00096a061]
[35]
Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci 2014; 111(47): 16836-41.
[http://dx.doi.org/10.1073/pnas.1415518111] [PMID: 25385600]
[36]
Yagoda N, von Rechenberg M, Zaganjor E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 2007; 447(7146): 865-9.
[http://dx.doi.org/10.1038/nature05859] [PMID: 17568748]
[37]
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 2012; 149(5): 1060-72.
[http://dx.doi.org/10.1016/j.cell.2012.03.042] [PMID: 22632970]
[38]
Torii S, Shintoku R, Kubota C, et al. An essential role for functional lysosomes in ferroptosis of cancer cells. Biochem J 2016; 473(6): 769-77.
[http://dx.doi.org/10.1042/BJ20150658] [PMID: 26759376]
[39]
Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 2008; 15(3): 234-45.
[http://dx.doi.org/10.1016/j.chembiol.2008.02.010] [PMID: 18355723]
[40]
Yang WS, Stockwell BR. Ferroptosis: Death by lipid peroxidation. Trends Cell Biol 2016; 26(3): 165-76.
[http://dx.doi.org/10.1016/j.tcb.2015.10.014] [PMID: 26653790]
[41]
Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J 2021.
[PMID: 34092035]
[42]
Krainz T, Gaschler MM, Lim C, Sacher JR, Stockwell BR, Wipf P. A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis. ACS Cent Sci 2016; 2(9): 653-9.
[http://dx.doi.org/10.1021/acscentsci.6b00199] [PMID: 27725964]
[43]
Probst L, Dächert J, Schenk B, Fulda S. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death. Biochem Pharmacol 2017; 140: 41-52.
[http://dx.doi.org/10.1016/j.bcp.2017.06.112] [PMID: 28595877]
[44]
Shah R, Margison K, Pratt DA. The potency of diarylamine radical-trapping antioxidants as inhibitors of ferroptosis underscores the role of autoxidation in the mechanism of cell death. ACS Chem Biol 2017; 12(10): 2538-45.
[http://dx.doi.org/10.1021/acschembio.7b00730] [PMID: 28837769]
[45]
Conrad M, Lorenz SM, Proneth B. Targeting ferroptosis: New hope for as-yet-incurable diseases. Trends Mol Med 2021; 27(2): 113-22.
[http://dx.doi.org/10.1016/j.molmed.2020.08.010] [PMID: 32958404]
[46]
Liu J, Bandyopadhyay I, Zheng L, Khdour OM, Hecht SM. Antiferroptotic activity of phenothiazine analogues: A novel therapeutic strategy for oxidative stress related disease. ACS Med Chem Lett 2020; 11(11): 2165-73.
[http://dx.doi.org/10.1021/acsmedchemlett.0c00293] [PMID: 33214825]
[47]
Lei P, Bai T, Sun Y. Mechanisms of ferroptosis and relations with regulated cell death: A review. Front Physiol 2019; 10: 139-9.
[http://dx.doi.org/10.3389/fphys.2019.00139] [PMID: 30863316]
[48]
Kajarabille N, Latunde-Dada GO. Programmed cell-death by ferroptosis: Antioxidants as mitigators. Int J Mol Sci 2019; 20(19): 4968.
[http://dx.doi.org/10.3390/ijms20194968] [PMID: 31597407]
[49]
Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 2017; 13(1): 91-8.
[http://dx.doi.org/10.1038/nchembio.2239] [PMID: 27842070]
[50]
Fang Y, Tan Q, Zhou H, Gu Q, Xu J. Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents. Eur J Med Chem 2022; 231: 114151.
[http://dx.doi.org/10.1016/j.ejmech.2022.114151] [PMID: 35123296]
[51]
Chattopadhyay S, Schreiber SL. Compounds and methods for increasing tumor infiltration by immune cells. U.S. Patent. 0,120,445, 2016.
[52]
Gao M, Ramasamy R, Jiang X. Ferroptosis and glutaminolysis inhibitors and methods of treatment. U.S. Patent 0,110,770, 2016.
[53]
Stockwell BR, Skouta R, Dixon S. Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders. U.S. Patent 0,299,107, 2019.
[54]
Wang L, Wang A, Fu Q, et al. Ferroptosis plays an important role in promoting ionizing radiation-induced intestinal injuries. Biochem Biophys Res Commun 2022; 595: 7-13.
[http://dx.doi.org/10.1016/j.bbrc.2022.01.068] [PMID: 35091109]
[55]
Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell 2021; 12(11): 836-57.
[http://dx.doi.org/10.1007/s13238-021-00841-y] [PMID: 33891303]
[56]
Naz N, Ahmad S, Cameron S, et al. Differential regulation of ferritin subunits and iron transport proteins: An effect of targeted hepatic X-irradiation. BioMed Res Int 2013; 2013: 1-8.
[http://dx.doi.org/10.1155/2013/353106] [PMID: 24693535]
[57]
Ye LF, Chaudhary KR, Zandkarimi F, et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol 2020; 15(2): 469-84.
[http://dx.doi.org/10.1021/acschembio.9b00939] [PMID: 31899616]
[58]
Chanutin A, Ludewig S. Effect of whole body X-irradiation on serum iron. Am J Physiol 1951; 166(2): 380-3.
[http://dx.doi.org/10.1152/ajplegacy.1951.166.2.380] [PMID: 14857189]
[59]
Xie L, Zhang X, Hu X, Min X, Zhou Q, Zhang H. Mechanisms of an increased level of serum iron in gamma-irradiated mice. Radiat Environ Biophys 2016; 55(1): 81-8.
[http://dx.doi.org/10.1007/s00411-015-0623-4] [PMID: 26511140]
[60]
Kim KU, Xiao J, Ni HT, et al. Changes in expression of transferrin, insulin-like growth factor 1, and interleukin 4 receptors after irradiation of cells of primary malignant brain tumor cell lines. Radiat Res 2003; 160(2): 224-31.
[http://dx.doi.org/10.1667/RR3040] [PMID: 12859234]
[61]
Gong JK, Glomski CA, Guo Y. A lifelong, wide-range radiation biodosimeter: Erythrocytes with transferrin receptors. Health Phys 1999; 77(6): 713-8.
[http://dx.doi.org/10.1097/00004032-199912000-00016] [PMID: 10568551]
[62]
Zhang X, Li X, Zheng C, et al. Ferroptosis, a new form of cell death defined after radiation exposure. Int J Radiat Biol 2022; 98(7): 1201-9.
[http://dx.doi.org/10.1080/09553002.2022.2020358] [PMID: 34982648]
[63]
Zhang X, Tian M, Li X, et al. Hematopoietic protection and mechanisms of ferrostatin-1 on hematopoietic acute radiation syndrome of mice. Int J Radiat Biol 2021; 97(4): 464-73.
[http://dx.doi.org/10.1080/09553002.2021.1876956] [PMID: 33464146]
[64]
Wang X, Chen Y, Wang X, et al. Stem cell factor sox2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11. Cancer Res 2021; 81(20): 5217-29.
[http://dx.doi.org/10.1158/0008-5472.CAN-21-0567] [PMID: 34385181]
[65]
Xie LW, Cai S, Zhao TS, Li M, Tian Y. Green tea derivative (-)-epigallocatechin-3-gallate (EGCG) confers protection against ionizing radiation-induced intestinal epithelial cell death both in vitro and in vivo. Free Radic Biol Med 2020; 161: 175-86.
[http://dx.doi.org/10.1016/j.freeradbiomed.2020.10.012] [PMID: 33069855]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy